ArticleNeurology(R) neuroimmunology & neuroinflammation2017
Contribution of blood vessels to retinal nerve fiber layer thickness in NMOSD.
Abstract read
In one paragraph
Article in Neurology(R) neuroimmunology & neuroinflammation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Optical coherence tomography angiography helps distinguish multiple sclerosis from AQP4-IgG-seropositive neuromyelitis optica spectrum disorder.Brain and behavior · 2021Article
- Superficial Macula Capillary Complexity Changes Are Associated With Disability in Neuromyelitis Optica Spectrum Disorders.Frontiers in neurology · 2021Article
- Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders.Neurology(R) neuroimmunology & neuroinflammation · 2020Observational
- Visualizing the Central Nervous System: Imaging Tools for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.Frontiers in neurology · 2020Review
- Retinal correlates of neurological disorders.Therapeutic advances in chronic disease · 2019Review
- Active contour method for ILM segmentation in ONH volume scans in retinal OCT.Biomedical optics express · 2018Article
- Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy.The EPMA journal · 2018Review
- Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis.Frontiers in neurology · 2018Review
- [Optical coherence tomography in neuromyelitis optica spectrum disorders].Der Nervenarzt · 2017Review
- CuBe: parametric modeling of 3D foveal shape using cubic Bézier.Biomedical optics express · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Frederike C OertelNeuroCure Clinical Research Center (F.C.O., H.Z., J.M., M.W., E.M.K., T.O., F. Pache, J.B.-S., F. Paul, A.U.B.), Department of Neurology (F. Pache, J.B.-S., K.R., F. Paul), Charité-Universitätsmedizin Berlin; and Experimental and Clinical Research Center (J.B.-S., F. Paul), Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Germany.
Hanna ZimmermannNeuroCure Clinical Research Center (F.C.O., H.Z., J.M., M.W., E.M.K., T.O., F. Pache, J.B.-S., F. Paul, A.U.B.), Department of Neurology (F. Pache, J.B.-S., K.R., F. Paul), Charité-Universitätsmedizin Berlin; and Experimental and Clinical Research Center (J.B.-S., F. Paul), Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Germany.
Janine MikolajczakNeuroCure Clinical Research Center (F.C.O., H.Z., J.M., M.W., E.M.K., T.O., F. Pache, J.B.-S., F. Paul, A.U.B.), Department of Neurology (F. Pache, J.B.-S., K.R., F. Paul), Charité-Universitätsmedizin Berlin; and Experimental and Clinical Research Center (J.B.-S., F. Paul), Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Germany.
Maria WeinholdNeuroCure Clinical Research Center (F.C.O., H.Z., J.M., M.W., E.M.K., T.O., F. Pache, J.B.-S., F. Paul, A.U.B.), Department of Neurology (F. Pache, J.B.-S., K.R., F. Paul), Charité-Universitätsmedizin Berlin; and Experimental and Clinical Research Center (J.B.-S., F. Paul), Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Germany.
Ella Maria KadasNeuroCure Clinical Research Center (F.C.O., H.Z., J.M., M.W., E.M.K., T.O., F. Pache, J.B.-S., F. Paul, A.U.B.), Department of Neurology (F. Pache, J.B.-S., K.R., F. Paul), Charité-Universitätsmedizin Berlin; and Experimental and Clinical Research Center (J.B.-S., F. Paul), Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Germany.
Timm OberwahrenbrockNeuroCure Clinical Research Center (F.C.O., H.Z., J.M., M.W., E.M.K., T.O., F. Pache, J.B.-S., F. Paul, A.U.B.), Department of Neurology (F. Pache, J.B.-S., K.R., F. Paul), Charité-Universitätsmedizin Berlin; and Experimental and Clinical Research Center (J.B.-S., F. Paul), Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Germany.
Florence PacheNeuroCure Clinical Research Center (F.C.O., H.Z., J.M., M.W., E.M.K., T.O., F. Pache, J.B.-S., F. Paul, A.U.B.), Department of Neurology (F. Pache, J.B.-S., K.R., F. Paul), Charité-Universitätsmedizin Berlin; and Experimental and Clinical Research Center (J.B.-S., F. Paul), Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Germany.
Judith Bellmann-StroblNeuroCure Clinical Research Center (F.C.O., H.Z., J.M., M.W., E.M.K., T.O., F. Pache, J.B.-S., F. Paul, A.U.B.), Department of Neurology (F. Pache, J.B.-S., K.R., F. Paul), Charité-Universitätsmedizin Berlin; and Experimental and Clinical Research Center (J.B.-S., F. Paul), Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Germany.
Klemens RuprechtNeuroCure Clinical Research Center (F.C.O., H.Z., J.M., M.W., E.M.K., T.O., F. Pache, J.B.-S., F. Paul, A.U.B.), Department of Neurology (F. Pache, J.B.-S., K.R., F. Paul), Charité-Universitätsmedizin Berlin; and Experimental and Clinical Research Center (J.B.-S., F. Paul), Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Germany.
Friedemann PaulNeuroCure Clinical Research Center (F.C.O., H.Z., J.M., M.W., E.M.K., T.O., F. Pache, J.B.-S., F. Paul, A.U.B.), Department of Neurology (F. Pache, J.B.-S., K.R., F. Paul), Charité-Universitätsmedizin Berlin; and Experimental and Clinical Research Center (J.B.-S., F. Paul), Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Germany.
Alexander U BrandtNeuroCure Clinical Research Center (F.C.O., H.Z., J.M., M.W., E.M.K., T.O., F. Pache, J.B.-S., F. Paul, A.U.B.), Department of Neurology (F. Pache, J.B.-S., K.R., F. Paul), Charité-Universitätsmedizin Berlin; and Experimental and Clinical Research Center (J.B.-S., F. Paul), Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Germany.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.